Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases [Phase 2]
Phase 2 clinical trial evaluating prophylactic anti-seizure medication versus no anti-seizure medication in patients with primary motor cort…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Liquid Biopsy Monitoring Of EGFR T790M in Advanced Non-Small Cell Lung Cancer
Clinical trial update describing liquid biopsy monitoring of EGFR T790M in advanced Non-Small Cell Lung Cancer. The study status is complete…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
A clinical trial comparing minimally invasive segmentectomy to lobectomy for non-small cell lung cancer to evaluate clinical outcomes and qu…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction [Phase 2]
Phase 2 clinical trial evaluating same-day planning and margin-reduced stereotactic radiation for growing or changing brain metastases. The …
-
CLINICAL_TRIALS other · 2026-03-19Clinical Trial Update: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC [Phase 3]
Phase 3 clinical trial comparing SHR-A2009 with platinum-based chemotherapy in EGFR-mutated advanced or metastatic non-small cell lung cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Fiber-Boost Randomized Controlled Trial [NA]
Clinical trial update shows a fiber-boost randomized controlled trial for non-small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR) [Phase 3]
Phase 3 trial update on Tumor Treating Fields (TTFields) at 150 kHz used alongside standard therapies for stage IV non-small cell lung cance…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors [Phase 1]
This update reports on a Phase 1 trial testing the combination of sonidegib and pembrolizumab in patients with various advanced solid tumors…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Regeneron is evaluating REGN5093 in adults with MET-altered advanced non-small cell lung cancer in a Phase 1/2 study. The trial status is re…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases [Phase 1, Phase 2]
A Phase 1/2 trial evaluating Bintrafusp alfa in combination with Pimasertib for brain metastases has been terminated, with results posted in…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification [Phase 1]
BeiGene is conducting a first-in-human Phase 1 study of BGB-53038, a pan-KRAS inhibitor, as a monotherapy or in combination, in participants…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors [Phase 1, Phase 2]
Roche is conducting a dose-escalation Phase 1/2 trial of a PD-1/LAG-3 bispecific antibody in patients with advanced or metastatic solid tumo…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies [Phase 1, Phase 2]
Phase 1/2 trial of plinabulin with radiation and immunotherapy in select advanced cancers after progression on PD-1/PD-L1 therapy was termin…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Effect of Pre-operative Exercise Training on Cardiorespiratory Fitness in Patients With Locally Advanced Non-small Cell Lung Cancer Undergoing Induction Chemo-immunotherapy Followed by Surgery - a Randomized Controlled Study [NA]
This clinical trial registry entry describes a randomized controlled study to assess whether pre-operative exercise training improves cardio…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Clinical trial update on paclitaxel therapeutic drug monitoring in cancer patients; the study is currently suspended.
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]
A clinical trial update describing STK-012 alone or in combination for advanced lung cancer and other solid tumors, currently recruiting in …
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes
A clinical trial update indicates recruitment is ongoing for a multi-omics study of early-stage lung cancer with distinct phenotypes, includ…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC) [Phase 3]
A Phase 3 trial compares the efficacy and safety of adding a new treatment to tislelizumab in non-small cell lung cancer. The study is curre…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation [Phase 1, Phase 2]
Novartis reports an update on the JDQ-443 clinical program in advanced KRAS G12C-mutant solid tumors, including non-small cell lung cancer a…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for FMC-376 in KRAS G12C-mutated solid tumors, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA) [Phase 2]
This clinical trial update reports a Phase 2 study (LADOGA) evaluating durvalumab with oleclumab after chemoradiation in locally advanced un…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing SGN-B6A to docetaxel in previously treated non-small cell lung cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 [Phase 2, Phase 3]
Ongoing Phase 2 and Phase 3 trials from Mirati evaluate adagrasib as a standalone therapy and in combination with pembrolizumab for KRAS G12…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC [NA]
Clinical trial update describing a study of Progel Platinum to reduce air leaks after VATS lobectomy in non-small cell lung cancer; the tria…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004) [Phase 3]
Phase 3 trial evaluating eftilagimod alfa in combination with pembrolizumab and chemotherapy versus placebo with pembrolizumab and chemother…